ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |
RICE HALL JAMES & ASSOCIATES, LLC | 696,065 | $14,505,995 | 0.92% |
Frazier Life Sciences Management, L.P. | 630,897 | $13,147,893 | 0.87% |
SECTORAL ASSET MANAGEMENT INC | 209,960 | $4,375,566 | 0.85% |
Penn Capital Management Company, LLC | 289,283 | $6,049,141 | 0.62% |
AlphaCentric Advisors LLC | 50,000 | $1,042,000 | 0.59% |
Hood River Capital Management LLC | 877,827 | $18,293,915 | 0.59% |
Ghost Tree Capital, LLC | 80,000 | $1,667,200 | 0.55% |
Nan Fung Group Holdings Ltd | 29,984 | $624,867 | 0.51% |
Soleus Capital Management, L.P. | 244,627 | $5,098,027 | 0.47% |
CROWN ADVISORS MANAGEMENT, INC. | 30,000 | $625 | 0.44% |
External links
This page lists ACADIA PHARMACEUTICALS INC's shareholders in Q3 2023. To view ACADIA PHARMACEUTICALS INC's shareholder history, click here.